To further support its mission and vision, Rutgers Cancer Institute of New Jersey has modified its leadership structure by elevating two associate director functions to deputy director positions.
Eugenia Girda, MD, FACOG, gynecologic oncologist in the Gynecologic Oncology Program at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health is lead author of a recent clinical practice statement exploring therapies for cervical cancer.
Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program and only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, and associate professor of pharmacology and pediatrics at Rutgers Robert Wood Johnson Medical School, has received a $500,000 collaborative grant from Gabrielle's Angel Foundation for Cancer Research and The Mark Foundation for Cancer Research.
Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present an extensive array of hematology/oncology data from their clinical research program at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, being held in San Diego, California (and virtually) from December 9-12, 2023.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Louise Ligresti, MD, as chief of Cancer Survivorship at New Jersey’s leading cancer center and the only one in the state designated as a Comprehensive Cancer Center by the National Cancer Institute.
Elevating the combined strengths of the nationally recognized cancer center and the state’s largest academic health system will revolutionize care in New Jersey and beyond.
Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, the state’s leading cancer program and only NCI-designated Comprehensive Cancer Center and assistant professor of pharmacology at Rutgers Robert Wood Johnson Medical School, has received $800,000 from the V Foundation for Cancer Research, a premier cancer research charity, to support his research on acute lymphoblastic leukemia (ALL).
Investigators from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, the state’s leading cancer program and only National Cancer Institute-designated Comprehensive Cancer Center, investigated genomic alterations based on KRAS status to identify mutations in patients with KRAS wild type (WT).
Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present new, novel, and expansive radiation oncology data from their clinical research program at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting, to be held in San Diego from October 1-4.
While researchers continue to make advancements in cancer detection and treatment for breast cancer, one of the best ways to tackle the disease is through early detection and screening with mammography.
What young women should know about breast cancer and screening.
Researchers are working to improve outcomes for Black women with breast cancer – including through increased participation in clinical trials, which helps find better ways to prevent, diagnose and treat cancer.
David M. Golombos, MD, addresses prostate cancer topics
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Adrienne Phillips, MD, MPH, as director of Cell Therapy and Bone Marrow Transplantation Northern Regions at New Jersey’s leading cancer program and only National Cancer Institute (NCI)- Designated Comprehensive Cancer Center.
Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS), together with other collaborating groups, have discovered the first lipid vascular ‘ZIP code’ in the lungs, with implications for improved diagnostics and treatments, including patients with severe human respiratory diseases such as emphysema, COVID-19, COPD and lung cancer.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Niketa C. Shah, MD, as chief of Pediatric Bone Marrow Transplantation and Cellular Therapies at New Jersey’s leading cancer program.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
